JP2006518333A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006518333A5 JP2006518333A5 JP2004563931A JP2004563931A JP2006518333A5 JP 2006518333 A5 JP2006518333 A5 JP 2006518333A5 JP 2004563931 A JP2004563931 A JP 2004563931A JP 2004563931 A JP2004563931 A JP 2004563931A JP 2006518333 A5 JP2006518333 A5 JP 2006518333A5
- Authority
- JP
- Japan
- Prior art keywords
- propyl
- tetrahydro
- oxadiazol
- butanoic acid
- naphthyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43546702P | 2002-12-20 | 2002-12-20 | |
| PCT/US2003/040898 WO2004058254A1 (en) | 2002-12-20 | 2003-12-22 | Heteroarylalkanoic acids as integrin receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006518333A JP2006518333A (ja) | 2006-08-10 |
| JP2006518333A5 true JP2006518333A5 (https=) | 2007-02-01 |
Family
ID=32682246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004563931A Withdrawn JP2006518333A (ja) | 2002-12-20 | 2003-12-22 | インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050043344A1 (https=) |
| EP (1) | EP1592421A1 (https=) |
| JP (1) | JP2006518333A (https=) |
| AU (1) | AU2003299807A1 (https=) |
| BR (1) | BR0317600A (https=) |
| CA (1) | CA2507699A1 (https=) |
| MX (1) | MXPA05006727A (https=) |
| WO (1) | WO2004058254A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070011458A (ko) | 2004-04-08 | 2007-01-24 | 탈자진 인코포레이티드 | 키나제의 벤조트리아진 억제제 |
| PL382308A1 (pl) | 2004-08-25 | 2007-08-20 | Targegen, Inc. | Związki heterocykliczne i sposoby stosowania |
| US8604042B2 (en) | 2005-11-01 | 2013-12-10 | Targegen, Inc. | Bi-aryl meta-pyrimidine inhibitors of kinases |
| CN103626742B (zh) | 2005-11-01 | 2017-04-26 | 塔格根公司 | 激酶的联-芳基间-嘧啶抑制剂 |
| US8133900B2 (en) | 2005-11-01 | 2012-03-13 | Targegen, Inc. | Use of bi-aryl meta-pyrimidine inhibitors of kinases |
| AU2006332694A1 (en) * | 2005-12-30 | 2007-07-12 | Alantos Pharmaceuticals, Holding, Inc. | Substituted bis-amide metalloprotease inhibitors |
| US20080306116A1 (en) * | 2007-06-08 | 2008-12-11 | Christ Andreas D | Aryloxazole, aryloxadiazole and benzimidazole derivatives |
| ES2457822T3 (es) * | 2007-11-08 | 2014-04-29 | The General Hospital Corporation | Procedimientos y composiciones de tratamiento de enfermedades proteinúricas |
| PT2544679T (pt) | 2010-03-12 | 2019-07-11 | Omeros Corp | Inibidores de pde-10 e composições e métodos relacionados |
| US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| CA2816957A1 (en) | 2010-11-07 | 2012-05-10 | Targegen, Inc. | Compositions and methods for treating myelofibrosis |
| US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
| CN102381961B (zh) * | 2011-09-03 | 2014-01-15 | 四川大学 | 3-苯基戊二酸类化合物、其制备方法和用途 |
| US8901144B2 (en) | 2013-02-07 | 2014-12-02 | Scifluor Life Sciences, Llc | Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives |
| HRP20171873T1 (hr) | 2013-02-07 | 2018-02-23 | Scifluor Life Sciences, Inc | Fluorinirani antagonisti integrina |
| GB201305668D0 (en) | 2013-03-28 | 2013-05-15 | Glaxosmithkline Ip Dev Ltd | Avs6 Integrin Antagonists |
| PL3050878T3 (pl) | 2013-09-24 | 2022-01-24 | Fujifilm Corporation | Zawierający atom azotu związek lub jego sól, lub ich kompleks z metalem |
| NZ630803A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Optically active pde10 inhibitor |
| NZ716494A (en) | 2014-04-28 | 2017-07-28 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
| GB201417002D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| GB201417018D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417094D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417011D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| KR102647026B1 (ko) | 2015-02-19 | 2024-03-12 | 사이플루어 라이프 사이언시즈, 인크 | 플루오르화 테트라히드로나프티리디닐 노난산 유도체 및 이의 용도 |
| US9879002B2 (en) | 2015-04-24 | 2018-01-30 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| US9920045B2 (en) | 2015-11-04 | 2018-03-20 | Omeros Corporation | Solid state forms of a PDE10 inhibitor |
| GB201604680D0 (en) | 2016-03-21 | 2016-05-04 | Glaxosmithkline Ip Dev Ltd | Chemical Compounds |
| WO2018089353A1 (en) | 2016-11-08 | 2018-05-17 | Bristol-Myers Squibb Company | 3-substituted propionic acids as alpha v integrin inhibitors |
| CN110177787A (zh) * | 2016-12-29 | 2019-08-27 | 圣路易斯大学 | 整合素拮抗剂 |
| ES2904645T3 (es) * | 2017-11-07 | 2022-04-05 | Bristol Myers Squibb Co | Derivados de pirrolopirazina como inhibidores de integrina alfa v |
| CN115872926A (zh) * | 2021-09-26 | 2023-03-31 | 南通诺泰生物医药技术有限公司 | 三唑类抗真菌药及其中间体的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
| PT889877E (pt) * | 1996-03-29 | 2002-02-28 | Searle & Co | Derivados fenileno meta substituidos e sua utilizacao como antagonitas ou inibidores integrina alfa v beta3 |
| DE69713582T2 (de) * | 1996-03-29 | 2003-01-09 | G.D. Searle & Co., Chicago | Zimtsäurederivate und deren verwendung als integrin-antagonisten |
| DE19620041A1 (de) * | 1996-05-17 | 1998-01-29 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| EP1049693A1 (en) * | 1997-11-26 | 2000-11-08 | Du Pont Pharmaceuticals Company | 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS |
| JP2004511434A (ja) * | 2000-06-15 | 2004-04-15 | ファルマシア・コーポレーション | インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸 |
| CA2443332A1 (en) * | 2001-04-04 | 2002-10-17 | University Of Rochester | .alpha..nu..beta.3 integrin-binding polypeptide monobodies and their use |
| US6750215B2 (en) * | 2001-08-08 | 2004-06-15 | Pharmacia & Upjohn, S.P.A. | Substituted benzoxazines as integrin antagonists |
-
2003
- 2003-12-22 BR BR0317600-2A patent/BR0317600A/pt not_active IP Right Cessation
- 2003-12-22 EP EP03800081A patent/EP1592421A1/en not_active Withdrawn
- 2003-12-22 US US10/743,354 patent/US20050043344A1/en not_active Abandoned
- 2003-12-22 WO PCT/US2003/040898 patent/WO2004058254A1/en not_active Ceased
- 2003-12-22 CA CA002507699A patent/CA2507699A1/en not_active Abandoned
- 2003-12-22 AU AU2003299807A patent/AU2003299807A1/en not_active Abandoned
- 2003-12-22 MX MXPA05006727A patent/MXPA05006727A/es unknown
- 2003-12-22 JP JP2004563931A patent/JP2006518333A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006518333A5 (https=) | ||
| RU2352568C2 (ru) | [1,2,4]оксадиазолы (варианты), способ их получения, фармацевтическая композиция и способ ингибирования активации метаботропных глютаматных рецепторов-5 | |
| JP2015533157A5 (https=) | ||
| JP2004531473A5 (https=) | ||
| JP2020527560A5 (https=) | ||
| HRP20160104T1 (hr) | Farmaceutski pripravak za liječenje ili prevenciju glaukoma | |
| RU2014152625A (ru) | Конденсированные с гетероарилкетонами азадекалины - модуляторы глюкокортикоидных рецепторов | |
| RU2007107177A (ru) | Соединения и композиции, как модуляторы ядерных рецепторов стероидных гормонов | |
| JP2017501981A5 (https=) | ||
| JP2013519680A5 (https=) | ||
| JP2013517278A5 (https=) | ||
| JP2018535999A5 (https=) | ||
| RU2018138047A (ru) | Гетероциклические вещества - агонисты gpr119 | |
| JP2007510689A5 (https=) | ||
| RU2004121029A (ru) | Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1) | |
| JP2013517281A5 (https=) | ||
| JP2008546836A (ja) | 新規な用途 | |
| JP2009524677A5 (https=) | ||
| AR103807A1 (es) | Tratamiento de la pancreatitis | |
| JP2014510132A5 (https=) | ||
| HRP20170029T1 (hr) | Derivati triazola ili njihove soli | |
| RU2013139662A (ru) | Ингибирование il17 и ifn-гамма для лечения аутоиммунного воспаления | |
| RU2008141511A (ru) | Конденсированные гетероциклические соединения и их применение в качестве модуляторов mglur5 | |
| JP2021518377A5 (https=) | ||
| JP2017532364A5 (https=) |